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Learning Objectives: 
Upon completion of this learning activity, participants will be able to: 
• Discuss the pathophysiology of COPD.
• Describe the basic considerations and treatments in individuals suffering from COPD.
• Discuss appropriate ventilator management for patients with COPD.
Case:  A 68 year old man with COPD just underwent a laparoscopic cholecystectomy (under 
general anesthesia).  Following the procedure, the patient was extubated in the operating 
room and was transported to the post-anesthesia care unit (PACU) with supplemental oxygen 
(2L nasal cannula).  During his time in the PACU, the nurse notes the patient is struggling to 
breathe and he continues to require supplemental oxygen (he does not require supplemental 
oxygen at home).  Upon arrival to the PACU, you note the patient’s oxygen needs have 
increased significantly (now on 60% FiO2 via high-flow nasal cannula) and his respiratory rate 
is 25-30 breaths per minute. 
1) What is COPD?
• COPD (Chronic Obstructive Pulmonary Disease) is a common condition characterized by
the obstruction of airway flow.  According to the Global Initiative for Chronic Obstructive
Lung Disease (GOLD),COPD is defined as follows:
o "COPD is a common, preventable, and treatable disease that is characterized by
persistent respiratory symptoms and airflow limitation that is due to airway and/or
alveolar abnormalities usually caused by significant exposure to noxious particles or
gases. The chronic airflow limitation that characterizes COPD is caused by a mixture of
small airways disease (e.g., obstructive bronchiolitis) and parenchymal destruction
(emphysema), the relative contributions of which vary from person to person. Chronic
inflammation causes structural changes, small airways narrowing, and destruction of
lung parenchyma. A loss of small airways may contribute to airflow limitation and
mucociliary dysfunction, a characteristic feature of the disease."
____________________________________________________
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o In short, COPD is a chronic inflammatory lung disease that causes obstructed airflow 
from the lungs. 
 
 
2) What other causes of respiratory distress besides COPD are in your differential diagnosis?   
 
• Residual Medication Effects (excessive opioids, residual muscle relaxant) 
• Myocardial Infarction 
• CHF/Fluid Overload/Pulmonary Edema 
• Obstructive Sleep Apnea 
• Aspiration Event 
• Pulmonary Embolism 
• Atelectasis 
• Residual CO2 from Abdominal Insufflation 
• Splinting from inadequate Pain Control (inability to take deep breaths and adequately 
cough) 
• Pneumothorax. 
• Pneumonia. 
 
3) You suspect the patient’s COPD is playing a significant role in the patient’s respiratory 
distress, but you are aware there could be other factors as well.  What steps would you 
take to investigate the cause of the patient’s respiratory distress? 
 
• The assessment should begin with a directed bedside physical exam (although studies 
can also be ordered while you are beginning your initial assessment.)  Diagnostic studies 
should also be considered to assess for the cause of the patient’s distress (see below).  
The patient’s anesthesia record should also be reviewed along with the patient’s medical 
history to assess for possible residual drug effects and fluid overload. 
 
•  Vital signs: BP, HR, RR, oxygen saturation, temp 
• Physical Exam: 
o Visual Evaluation of the patient’s breathing pattern. 
o Evaluation of the patient’s airway for possible obstruction. 
o Auscultation of the patient’s heart and lungs. 
o Evaluation of volume status for possible volume overload (peripheral edema, JVD). 
o Assessment of vital signs and amount of oxygen/ventilator support. 
o Evaluation of the patient’s level of consciousness. 
• Laboratory Studies: 
o Arterial Blood Gas. 
• Imaging Studies/Other Studies: 
o Portable Chest X-ray. 
o Electrocardiogram. 
o Echocardiogram (bedside transthoracic echo by either you or the cardiology service) 
to evaluate for cardiovascular function, volume status, and pulmonary status 
(alveolar interstitial syndrome, pneumothorax, pleural effusion) 
o Train-of-Four Evaluation (for adequate muscle relaxant reversal evaluation). 
 
4) What findings in evaluation of the patient would be most consistent with an exacerbation 
of COPD? 
 
• Physical Exam:  The patient is likely awake and in visible respiratory distress.  SpO2 would 
be decreased despite the use of supplemental oxygen and his respiratory rate would be 
increased.  On auscultation, wheezing may be heard (although this may be absent is 
severe exacerbations).  There would not be signs of upper airway obstruction (for 
example, snoring).  With severe hypercarbia (greater than 90 mm Hg) mental status 
could be depressed. 
• Laboratory Studies:  An ABG would likely show some degree of hypoxemia and 
hypercarbia. 
• Imaging/Other Studies:  The patient’s chest x-ray would likely not show obvious 
pulmonary edema or infiltration but rather hyperinflated lungs (possibly with a flattened 
diaphragm, see image below). 
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5) Following your investigation, you feel confident the patient is suffering from an 
exacerbation of his COPD.  How would you manage and treat this patient? 
 
• Of note, COPD exacerbations typically are started by a type of “trigger.”  Common 
triggers may include infectious etiologies or an aspiration event.   
• Stabilization: The first step should be to stabilize the patient (ensure the patient is able 
to adequately oxygenate and ventilate while pharmacologic treatment is initiated). 
• Pharmacologic treatments:  Beta adrenergic agonists, anticholinergic agents, 
glucocorticoid therapy, and antibiotics (if infectious etiology).  Beta-adrenergic agents 
stimulate β (particularly β2) receptors on bronchial smooth muscle causing adenylyl 
cyclase to convert ATP to cAMP which results inhibition of myosin phosphorylation and 
lowering of intracellular calcium which ultimately results in bronchial smooth muscle 
relaxation (reducing obstruction and improving airflow).  Anticholinergic agents block 
muscarinic acetylcholine receptors which promotes the degradation of cGMP and this in 
turn decreases contractility of smooth muscle in lung (reducing obstruction and 
promoting better flow).  Anticholinergic medications also reduces mucus secretion.  
Glucocorticoid medications (both inhaled and intravenous) reduce inflammation of the 
airway by way of their steroidal activities.  The beta adrenergic and anticholinergic 
agents will be your most rapidly acting treatments to acutely manage the patient, but 
initiation of other treatments should be initiated if a COPD exacerbation is suspected. 
• Supportive Care: Oxygen therapy, non-invasive positive pressure ventilation (NIPPV), 
mechanical ventilation.  Transition from just supplemental oxygen to non-invasive 
positive pressure may be prompted by worsening oxygenation, worsening hypercarbia, 
or increased work of breathing.  Transition from NIPPV to traditional mechanical 
ventilation my be sought due to continued poor oxygenation and continued CO2 
retention despite NIPPV. 
 
6) Despite your efforts with support and pharmacologic treatments, the patient’s respiratory 
status continues to worsen, and the patient requires mechanical ventilation.   What are 
the ventilator strategies that need to be considered when providing mechanical 
ventilation for a patient with COPD? 
 
• When a patient with COPD (especially in an exacerbation) requires mechanical 
ventilation, remember the two primary pathophysiologic issues that contribute to acute 
respiratory failure in COPD:  increased airway resistance and dynamic hyperinflation. 
• The ventilator strategies in such a patient has two aims:  correcting the gas exchange 
issue and identifying/preventing dynamic hyperinflation. 
o Correction of gas exchange can be achieved by allowing adequate time for 
exhalation, this can be accomplished by allowing an increased proportion of time 
for exhalation.  It is not uncommon for patients with COPD to require an inspiratory 
time: expiratory time ratio (I:E ratio) of 1:3 to 1:5.  Optimization of sedation may 
allow for better synchronization with the ventilator. 
o Dynamic hyperinflation should be suspected if airway pressures progressively rise 
and/or if it appears that each breath is not being entirely expired.  Severe 
hyperinflation can lead to hemodynamic compromise and even pneumothorax. 
o Preventive measures against hyperdynamic inflation include avoiding excessive 
minute ventilation (reductions in tidal volume and respiratory rate to allow more 
time for expiration), adjustment of I:E ratio (see above), and selection of 
appropriate ventilator mode. 
• Overall goals of ventilation: 
o Minimize airway pressures. 
o Minimize work of breathing 
o Maximize expiratory time for each breath delivered. 
o Avoid excessive ventilation (over correction of CO2). 
o It should be noted, in those with COPD exacerbations, mechanical ventilation 
doesn’t solve the problem, it only supports ventilation while the exacerbation is 
treated.  The goal should always be prompt recognition and treatment of the 
underlying cause. 
 
7)  What is “auto-PEEP?” 
 
• This is also known as intrinsic peep.  This occurs when ventilator settings produce an I:E) 
ratio that does not allow adequate time for expiration.  This means a subsequent breath 
is delivered prior to complete emptying from the previous breath.  This gas trapping can 
cause significant elevations in end-expiratory pressure, leading to increases in airway 
pressures and intrathoracic pressure.  Hypotension and barotrauma (causing 
pneumothorax) are potential complications.   
• Because COPD increases the required expiratory time, mechanically ventilated patients 
are at high risk for auto-PEEP.  The most effective way of avoid/combating auto-PEEP is 
increasing the actual time for expiration made available for each breath.  Optimization 
of ventilatory synchrony, avoidance of excessive minute ventilation, and appropriate 
ventilator mode selection are also important considerations.  
 
8) What ventilator strategy would you employ if the initial ABG comes back with 
pH – 7.23 
paCO2 – 81 
paO2- 89 
Bicarb – 35 
 
• Many individuals with COPD are chronic retainers of CO2.  Mechanisms of CO2 retention 
in these individuals include the disruption of capillary beds, airway obstruction (leading 
to hyperinflation), and reduced lung compliance all leading to an increase in dead space 
(V/Q mismatch).  This chronic increase in CO2 will cause a reduction in the patient’s pH 
but this is compensated by the renal system (the kidneys “hold on to” more or “dump” 
less bicarbonate.  With this in mind, one should aim to normalize the patient’s pH, not 
the paCO2.  Normalization of CO2 in someone with a chronic respiratory acidosis can 
cause a severe alkalemia.  Furthermore, a prolonged time on the ventilator with this 
correction may cause the kidneys to compensate and removed additional bicarbonate 
making weaning from the ventilator much more difficult. 
 
Suggested Readings: 
• Ahmed SM, Athar M.  Mechanical ventilation in patients with chronic obstructive 
pulmonary disease and bronchial asthma.  Indian J Anaesth. 2015;59(9):589-598. 
 
• Feller-Kopman DJ, Schwartzstein RM.  Mechanisms, causes, and effects of hypercapnia.  
Uptodate. 22 July 2019. Uptodate.com.   
 
• Jones J et al.  Chronic obstructive pulmonary disease.  Radiopaedia.  Radiopaedia.org. 
Accessed July 1, 2019.   
 
• Larose JA, Dellinger RP.  ICU Management of Obstructive Airway Disease.  In:  Roberts P, 
Todd SR.  Comprehensive Critical Care: Adult.  Mount Prospect, IL.  Society of Critical 
Care Medicine; 2012.   
 
• Plant P, Elliott M. Chronic obstructive pulmonary disease 9: Management of ventilatory 
failure in COPD. 2003; 58(6): 537-542. 
 
• McCory DC et al. Management of Acute Exacerbation of COPD: A Summary and 
Appraisal of Published Evidence. Chest. 2001; 119(4) 1190-1209. 
 
• Licker M et al. Perioperative medical management of patients with COPD. Int J Chron 
Obstruct Pulmon Dis. 2007 2(4): 493-515. 
 
• Marino PL.  Severe Airflow Obstruction.  In:  Marino PL.  The ICU Book 3rd Ed.  
Philadelphia, PA:  Lippincott Williams & Wilkins; 2007. 
 
• Quon BS, Gan WQ, Sin DD. Contemporary Management of Acute Exacerbation of COPD:  
A Systematic Review and Metaanalysis. Chest. 2008;133(3): 756-766. 
 
• Reddy RM, Guntupalli KK.  Review of ventilator techniques to optimize mechanical 
ventilation in acute exacerbation of chronic obstructive pulmonary disease.  Int J Chron 
Obtrsuct Pulmon Dis. 2007;2(4): 441-452. 
 
• Weinberg SE, Richard RM, Weiss JW.  Hypercapnia. N Engl J Med. 1989;  321: 1223-
1231. 
 
